We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DNUT:NASDAQKrispy Kreme, Inc. Analysis

Data as of 2026-07-16 - not real-time

$3.41

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Krispy Kreme’s price is trading just above a key support level, with the 20‑day SMA (≈$3.50) and 50‑day SMA (≈$3.51) converging below the current market price of $3.41, indicating limited upside momentum. The RSI sits in the mid‑40s, suggesting neutral to slightly bearish momentum, while the MACD histogram remains negative, reinforcing a bearish bias. Volatility is elevated at roughly 65% over the past 30 days and beta is below 1, meaning the stock moves less than the broader market but still experiences sharp price swings. Recent news of an 8.6% intraday rally tied to lower oil prices provided a short‑term boost, yet the underlying fundamentals remain weak. Operating margins are negative, the company carries a debt‑to‑equity ratio above 200%, and ROE is deeply in the red, making earnings sustainability a concern. Despite a dividend yield near 3.5%, the payout is built on negative earnings, raising doubts about its durability. The forward PE of about 64 and a price‑to‑book under 1 hint at a mixed valuation picture, while the upside/downside estimate of +27%/‑17% reflects modest upside potential if the turnaround succeeds. Overall, the stock faces a bearish technical backdrop, high valuation multiples relative to earnings, and a fragile balance sheet, with only limited catalysts on the horizon.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and RSI near neutral
  • Price hovering just above support with limited upside
  • Negative earnings and high debt amplify downside risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential turnaround from capital‑light initiatives
  • Dividend yield attractive if earnings improve
  • Volatility and balance‑sheet constraints limit confidence

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Price‑to‑book below 1 suggests hidden value
  • International footprint offers growth avenues
  • If the company can reverse negative margins, upside to target median price becomes plausible

Key Metrics & Analysis

Financial Health

Revenue Growth-2.20%
Profit Margin-33.36%
P/E Ratio63.8
ROE-58.15%
ROA-1.16%
Debt/Equity201.77
P/B Ratio0.9
Op. Cash Flow$74.9M
Free Cash Flow$22.4M

Technical Analysis

TrendBearish
RSI46.2
Support$3.26
Resistance$3.89
MA 20$3.50
MA 50$3.51
MA 200$3.65
MACDBearish
VolumeStable
Fear & Greed Index91.55

Valuation

Target Price$4.35
Upside/Downside27.57%
GradeOvervalued
TypeValue
Dividend Yield3.47%

Risk Assessment

Beta0.86
Volatility64.77%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.